Transactions
7
Insider / Medtronic plc
Fonseca Lidia
Director at Medtronic plc
- Company
- Medtronic plc
- First filing on record
- February 27, 2026
- Latest trade on record
- April 28, 2026
- SEC filings
- EDGAR ↗
Fonseca Lidia, Director at Medtronic plc, has disclosed 7 transactions in MDT, PFE since February 27, 2026: 0 purchases (0 open-market buys) and 3 sales, worth about $3.4M at the reported prices. The latest was filed April 29, 2026, 1 day after the trade.
Open-market buys
0
Sales
3
Avg. disclosure lag
1.9d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Fonseca Lidia made no purchases and 3 sales worth $1.5M, plus 4 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Fonseca Lidia has traded 2 stocks on record; the largest by dollars is PFE.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 3 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| F | Shares withheld for tax | 3 | 55,331 | $1.5M |
| A | Grant or award | 2 | 84,395 | — |
| M | Option exercise or conversion | 2 | 113,776 | $1.9M |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 7 | 0 | 3 · $1.5M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| MDT | Sell F | April 28, 2026 | April 29, 2026 | 1d | 207 | $82 | $17K | Form 4 ↗ | ||
| MDT | Other A | April 27, 2026 | April 29, 2026 | 2d | 2,111 | — | — | Form 4 ↗ | ||
| PFE | Other A | March 3, 2026 | March 5, 2026 | 2d | 82,284 | — | — | derivative | Form 4 ↗ | |
| PFE | Option / conversion M | February 25, 2026 | February 27, 2026 | 2d | 56,888 | — | — | derivative | Form 4 ↗ | |
| PFE | Sell F | February 25, 2026 | February 27, 2026 | 2d | 54,066 | $27 | $1.5M | Form 4 ↗ | ||
| PFE | Sell F | February 25, 2026 | February 27, 2026 | 2d | 1,058 | $27 | $29K | Form 4 ↗ | ||
| PFE | Option / conversion M | February 25, 2026 | February 27, 2026 | 2d | 56,888 | $34 | $1.9M | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| April 29, 2026 | Form 4 | 0001454944-26-000002 | 2 | published | EDGAR ↗ |
| March 5, 2026 | Form 4 | 0001225208-26-003311 | 1 | published | EDGAR ↗ |
| February 27, 2026 | Form 4 | 0001225208-26-002817 | 4 | published | EDGAR ↗ |
Other insiders at Medtronic plc
- NARAYEN SHANTANU Chair and CEO 88 rows
- BOURLA ALBERT Chairman & CEO 34 rows
- Quincey James Chairman 29 rows
- KIIL HARRY SKIP EVP & President Cardiovascular 22 rows
- ARNOLD CRAIG Director 17 rows
- NORA JOHNSON SUZANNE M Director 16 rows
- Blomquist Denise L. Chief Accounting Officer 13 rows
- DAMICO JENNIFER B. SVP & Controller 12 rows
- Gottlieb Scott Director 12 rows
- Buckley Mortimer J Director 11 rows
Everyone on file, with contracts and lobbying under the company's name: Medtronic plc.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 3 | 7 | February 27, 2026 | April 29, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.